352 related articles for article (PubMed ID: 26763072)
21. Mesenchymal stem cells used as carrier cells of oncolytic adenovirus results in enhanced oncolytic virotherapy.
Mahasa KJ; de Pillis L; Ouifki R; Eladdadi A; Maini P; Yoon AR; Yun CO
Sci Rep; 2020 Jan; 10(1):425. PubMed ID: 31949228
[TBL] [Abstract][Full Text] [Related]
22. Oncolytic Virotherapy and the Tumor Microenvironment.
Berkey SE; Thorne SH; Bartlett DL
Adv Exp Med Biol; 2017; 1036():157-172. PubMed ID: 29275471
[TBL] [Abstract][Full Text] [Related]
23. Oncolytic herpes simplex virus treatment of metastatic breast cancer.
Wang J; Hu P; Zeng M; Rabkin SD; Liu R
Int J Oncol; 2012 Mar; 40(3):757-63. PubMed ID: 22108767
[TBL] [Abstract][Full Text] [Related]
24. Oncolytic virotherapy in glioblastoma patients induces a tumor macrophage phenotypic shift leading to an altered glioblastoma microenvironment.
van den Bossche WBL; Kleijn A; Teunissen CE; Voerman JSA; Teodosio C; Noske DP; van Dongen JJM; Dirven CMF; Lamfers MLM
Neuro Oncol; 2018 Oct; 20(11):1494-1504. PubMed ID: 29796615
[TBL] [Abstract][Full Text] [Related]
25. Mechanisms of measles virus oncolytic immunotherapy.
Pidelaserra-Martí G; Engeland CE
Cytokine Growth Factor Rev; 2020 Dec; 56():28-38. PubMed ID: 32660751
[TBL] [Abstract][Full Text] [Related]
26. Mesenchymal stem cell carriers protect oncolytic measles viruses from antibody neutralization in an orthotopic ovarian cancer therapy model.
Mader EK; Maeyama Y; Lin Y; Butler GW; Russell HM; Galanis E; Russell SJ; Dietz AB; Peng KW
Clin Cancer Res; 2009 Dec; 15(23):7246-55. PubMed ID: 19934299
[TBL] [Abstract][Full Text] [Related]
27. Virotherapy with a type 2 herpes simplex virus-derived oncolytic virus induces potent antitumor immunity against neuroblastoma.
Li H; Dutuor A; Tao L; Fu X; Zhang X
Clin Cancer Res; 2007 Jan; 13(1):316-22. PubMed ID: 17200370
[TBL] [Abstract][Full Text] [Related]
28. Starvation-Induced Differential Virotherapy Using an Oncolytic Measles Vaccine Virus.
Scheubeck G; Berchtold S; Smirnow I; Schenk A; Beil J; Lauer UM
Viruses; 2019 Jul; 11(7):. PubMed ID: 31284426
[TBL] [Abstract][Full Text] [Related]
29. A novel armed oncolytic measles vaccine virus for the treatment of cholangiocarcinoma.
Lange S; Lampe J; Bossow S; Zimmermann M; Neubert W; Bitzer M; Lauer UM
Hum Gene Ther; 2013 May; 24(5):554-64. PubMed ID: 23550539
[TBL] [Abstract][Full Text] [Related]
30. Virus combinations and chemotherapy for the treatment of human cancers.
Kumar S; Gao L; Yeagy B; Reid T
Curr Opin Mol Ther; 2008 Aug; 10(4):371-9. PubMed ID: 18683102
[TBL] [Abstract][Full Text] [Related]
31. Oncolytic virotherapy synergism with signaling inhibitors: Rapamycin increases myxoma virus tropism for human tumor cells.
Stanford MM; Barrett JW; Nazarian SH; Werden S; McFadden G
J Virol; 2007 Feb; 81(3):1251-60. PubMed ID: 17108021
[TBL] [Abstract][Full Text] [Related]
32. Comparison of molecular strategies for breast cancer virotherapy using oncolytic adenovirus.
Bazan-Peregrino M; Carlisle RC; Hernandez-Alcoceba R; Iggo R; Homicsko K; Fisher KD; Halldén G; Mautner V; Shen Y; Seymour LW
Hum Gene Ther; 2008 Sep; 19(9):873-86. PubMed ID: 18710328
[TBL] [Abstract][Full Text] [Related]
33. [Construction of a new oncolytic virus oHSV2hGM-CSF and its anti-tumor effects].
Shi GL; Zhuang XF; Han XP; Li J; Zhang Y; Zhang SR; Liu BL
Zhonghua Zhong Liu Za Zhi; 2012 Feb; 34(2):89-95. PubMed ID: 22780924
[TBL] [Abstract][Full Text] [Related]
34. A measles virus selectively blind to signaling lymphocytic activation molecule shows anti-tumor activity against lung cancer cells.
Fujiyuki T; Yoneda M; Amagai Y; Obayashi K; Ikeda F; Shoji K; Murakami Y; Sato H; Kai C
Oncotarget; 2015 Sep; 6(28):24895-903. PubMed ID: 26317644
[TBL] [Abstract][Full Text] [Related]
35. Design of virotherapy for effective tumor treatment.
Garcia-Aragoncillo E; Hernandez-Alcoceba R
Curr Opin Mol Ther; 2010 Aug; 12(4):403-11. PubMed ID: 20677091
[TBL] [Abstract][Full Text] [Related]
36. Primary resistance phenomena to oncolytic measles vaccine viruses.
Noll M; Berchtold S; Lampe J; Malek NP; Bitzer M; Lauer UM
Int J Oncol; 2013 Jul; 43(1):103-12. PubMed ID: 23612727
[TBL] [Abstract][Full Text] [Related]
37. Oncolytic activity of avian influenza virus in human pancreatic ductal adenocarcinoma cell lines.
Kasloff SB; Pizzuto MS; Silic-Benussi M; Pavone S; Ciminale V; Capua I
J Virol; 2014 Aug; 88(16):9321-34. PubMed ID: 24899201
[TBL] [Abstract][Full Text] [Related]
38. An armed oncolytic herpes simplex virus expressing thrombospondin-1 has an enhanced in vivo antitumor effect against human gastric cancer.
Tsuji T; Nakamori M; Iwahashi M; Nakamura M; Ojima T; Iida T; Katsuda M; Hayata K; Ino Y; Todo T; Yamaue H
Int J Cancer; 2013 Jan; 132(2):485-94. PubMed ID: 22729516
[TBL] [Abstract][Full Text] [Related]
39. Enhanced killing of ovarian carcinoma using oncolytic measles vaccine virus armed with a yeast cytosine deaminase and uracil phosphoribosyltransferase.
Hartkopf AD; Bossow S; Lampe J; Zimmermann M; Taran FA; Wallwiener D; Fehm T; Bitzer M; Lauer UM
Gynecol Oncol; 2013 Aug; 130(2):362-8. PubMed ID: 23676551
[TBL] [Abstract][Full Text] [Related]
40. [Oncolytic Properties of a Mumps Virus Vaccine Strain in Human Melanoma Cell Lines].
Ammour YI; Ryabaya OO; Milovanova AV; Sidorov AV; Shohin IE; Zverev VV; Nasedkina TV
Mol Biol (Mosk); 2018; 52(4):659-666. PubMed ID: 30113031
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
